Article Information
History
- May 24, 2023.
Article Versions
- Version 1 (May 16, 2023 - 13:31).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Vidyasagar Devaprasad Dedeepiya1,
- Chockanathan Vetrievel2,
- Nobunao Ikewaki3,4,
- Koji Ichiyama5,
- Naoki Yamamoto6,
- Hiroto Kawashima7,
- Sudhakar S Bharatidasan8,
- Subramaniam Srinivasan1,
- Rajappa Senthilkumar5,9,
- Senthilkumar Preethy9 and
- Samuel JK Abraham1,5,9,10,11,12,*
- 1Mary-Yoshio Translational Hexagon (MYTH), Nichi-In Centre for Regenerative Medicine (NCRM), Chennai, India
- 2Be Well Hospitals, Chennai, Tamil Nadu, India
- 3Dept. of Medical Life Science, Kyushu University of Health and Welfare, Nobeoka, Miyazaki, Japan
- 4Institute of Immunology, Junsei Educational Institute, Nobeoka, Miyazaki, Japan
- 5Antony- Xavier Interdisciplinary Scholastics (AXIS), GN Corporation Co. Ltd., Kofu, Japan
- 6Genome Medical Sciences Project, National Center for Global Health and Medicine, Konodai, Ichikawa, Chiba, Japan
- 7Graduate School of Pharmaceutical Sciences, Chiba University, Chiba, Japan
- 8Department of Anaesthesia, Thunder Bay Regional Health Sciences Centre, Thunder Bay, Ontario, Canada
- 9Fujio-Eiji Academic Terrain (FEAT), Nichi-In Centre for Regenerative Medicine (NCRM), Chennai, India
- 10R & D, Sophy Inc., Japan
- 11Centre for Advancing Clinical Research (CACR), University of Yamanashi - School of Medicine, Chuo, Japan
- 12Levy-Jurgen Transdisciplinary Exploratory (LJTE), Global Niche Corp., Wilmington, DE, USA
- ↵*Corresponding author information:
Dr. Samuel JK Abraham,, II Department of Surgery & CACR, University of Yamanashi, Faculty of Medicine, Address for correspondence: 3-8, Wakamatsu, Kofu, 400-0866, Yamanashi, Japan, Email id- drsam{at}nichimail.jp; Alternate email id: drspp{at}nichimail.jp, Fax: +81-55-235-7569
Authors’ contributions NI and SA contributed to conception and design of the study. VD and CV helped in data collection. KI, NY, HK and SR helped with data analysis. SA and SP drafted the manuscript. SB and SS performed critical revision of the manuscript. All authors read and approved the final manuscript.
Posted May 24, 2023.
Improvement in Expanded Disability Status Scale (EDSS) and anti-inflammatory parameters in patients with multiple sclerosis following oral consumption of N-163 strain of Aureobasidium pullulans produced beta glucan in a pilot clinical study
